China Resources Group Acquires Sanjiu Group
This article was originally published in PharmAsia News
Sanjiu Enterprise Group has been acquired by state-owned China Resources Enterprise Ltd (CRG) to becomea wholly owned subsidiary. Sanjiu Pharmaceutical, the best performer among Sanjiu Group's listed enterprises, is expected to begin a share reform when the deal is finalized.The group has started transferring its well-known brand to Sanjiu Pharmaceutical according to the merger plan. By building on Sanjiu's strength, CRG plans to develop and expand its national pharmaceutical business. (Click here for more)
You may also be interested in...
Mylan and Pfizer’s Upjohn, already facing a delay to their proposed merger, may have to overcome regulatory barriers to get the deal over the line.
National export restrictions on medicines have been slammed by the international off-patent pharmaceutical industry as being “counter-productive” during the coronavirus crisis. The IGBA is instead urging international co-operation and transparency, pointing to a positive example of supply-chain connectivity in the Asia-Pacific region.
Claims circulated on social media that its Cebion supplement could prevent coronavirus has led Italy's Dompé to take legal action.